Adam Hansard Applied Therapeutics Inc. (APLT) insider trading activity

Adam Hansard is Chief Commercial Officer of Applied Therapeutics Inc.. Currently has a direct ownership of 732,919 shares of APLT, which is worth approximately $608,322. The most recent transaction as insider was on Mar 14, 2024, when has been sold 48,871 shares (Common Stock) at a price of $5.39 per share, resulting in proceeds of $263,414. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 733K

0% 3M change

6.25% 12M change

Total Value Held $608,322

Adam Hansard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2024	SELL Open market or private sale	$263,414 $5.39 p/Share	48,871 Reduced 6.25%	732,919 Common Stock
Dec 21 2023	BUY Grant, award, or other acquisition	-	400,000 Added 33.85%	781,790 Common Stock
Nov 30 2023	SELL Open market or private sale	$1,901 $1.97 p/Share	965 Reduced 0.25%	381,790 Common Stock
Sep 27 2023	SELL Open market or private sale	$26,244 $2.7 p/Share	9,720 Reduced 2.48%	382,755 Common Stock
Jan 11 2023	SELL Open market or private sale	$4,090 $0.91 p/Share	4,495 Reduced 4.64%	92,475 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	300,000 Added 43.32%	392,475 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	31,700 Added 24.64%	96,970 Common Stock
Dec 14 2021	BUY Grant, award, or other acquisition	-	31,700 Added 32.69%	65,270 Common Stock
May 26 2021	SELL Open market or private sale	$53,105 $18.35 p/Share	2,894 Reduced 7.94%	33,570 Common Stock

Adam Hansard

Chief Commercial Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLT shares.

Notify only if

Value

Insider Trading

Get notified when an Applied Therapeutics Inc. insider buys or sells APLT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Applied Therapeutics Inc.

Track Activities on APLT

Account